“…Additional in vivo studies, which examined the interactions of clonidine (a partial agonist for a 2A -ARs) and neuropeptide Y (NPY; a 36 amino acid neurotransmitter) on sleep-wakefulness cycles and arterial blood pressure control in both normal and spontaneously hypertensive rats (Fuxe et al, 1989;Fuxe, 1990;Yang et al, 1994), further supported the existence of receptor-receptor interactions and their potential functional relevance. As a logical consequence for the indications of direct physical interactions between neuropeptide and monoamine receptors, the term heteromerization was introduced to describe a specific interaction between different types of GPCRs (Zoli et al, 1993). The concept of the GPCR heterodimer was later confirmed by studies reporting that two non-functional GPCR monomers, GABA B1 and GABA B2 , can assemble in signaling heterodimers at the cell surface to transmit the inhibitory effect of the g-aminobutyric acid (GABA) neurotransmitter (Marshall et al, 1999): when expressed alone, the GABA B1 receptor is retained in the endoplasmic reticulum, and is able to reach the cell surface and bind GABA only in the presence of its partner, the GABA B2 receptor.…”